Allied Telesis Holdings KK
6835
Bleach
9162
Suncall
5985
Nakayo
6715
Rise
8836
JP Stock MarketDetailed Quotes
190A Chordia Therapeutics
- 263
- -3-1.13%
20min DelayMarket Closed Feb 17 15:30 JST
17.99BMarket Cap-8.45P/E (Static)
266High255Low1.19MVolume263Open266Pre Close309.66MTurnover93052wk High6.11%Turnover Ratio68.39MShares14252wk Low-31.11EPS TTM5.12BFloat Cap930Historical HighLossP/E (Static)19.46MShs Float142Historical Low-31.11EPS LYR4.14%Amplitude--Dividend TTM4.31P/B100Lot Size--Div YieldTTM
About Chordia Therapeutics Company
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
Company Profile
Symbol190A
Company NameChordia Therapeutics
Founded2017-10-12
MarketTSE Growth
Fiscal Year Ends08-31
Address2-26-1 Muraoka-Higashi Kanagawa
Zip Code251-0012
Phone03-6661-9543
Company Executives
- Name
- Position
- Salary
- Hiroshi Miyake
- Representative Director
- --
- Ayuko Hashimoto
- Independent Director
- --
- Akihiko Shimauchi
- Independent Director
- --
- Yukari Nishikata
- Independent Director
- --
- Satoshi Nakamura
- Independent Director
- --
- Kosuke Ishii
- Independent Director
- --